Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Oscient Pharmaceuticals Lays Off 180 Reps
PharmExec, 06/18/09
Oscient Pharmaceuticals, last week, announced that it will be ending all promotion activity for two of its treatments, and decreasing its sales force and marketing team by 180 bodies to compensate.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor